Expand your skills with these 4 free upcoming webinars
Explore topics from oligonucleotides and high-sensitivity troponin assays to therapeutic antibodies and advances in COVID-19 sample prep
Explore topics from oligonucleotides and high-sensitivity troponin assays to therapeutic antibodies and advances in COVID-19 sample prep
New capsid free antigen overcomes cross-reactivity difficulties, reducing the likelihood of false positives
Arvind Kothandaraman discusses the importance of detecting new SARS-CoV-2 variants and future trends in COVID-19 diagnostics
Enables researchers to generate more data in less time to support both preclinical and clinical studies
EKF Diagnostics expands into new manufacturing facility in Cardiff for PrimeStore MTM production
New crowdsourcing project to examine the ‘Translocation of Complex Macromolecules Across the Intestinal Epithelial Barrier’
This effort will study virus variants in the UK and South Africa and what that means for the transmission of SARS-CoV-2
With this addition, researchers can more easily screen for small molecule modulators of cGAS
Kickstart your new year with this compilation of top eBooks, techniques, webinars and videos across a range of scientific topics
Researchers have used Test and Trace data to find out why some individuals pass COVID-19 on to their contacts more easily than others
Advancement can enable greater certainty for providers and better outcomes for patients
Expanded list of instruments and reagents allows more options for labs running CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay
In this on-demand webinar, discover how to rapidly diagnose antimicrobial resistance for appropriate therapy
The extraction-free saliva-based test detects nucleic acid from the SARS-CoV-2 virus
The acquisition aims to meet continuing demand for COVID-related testing as well as develop point-of care tests for future infectious diseases
The collaboration aims to advance the scale-up of hMSC manufacturing for regenerative medicine
Cabenuva allows virologically suppressed adults with HIV to maintain viral suppression with 12 dosing days per year
Developed in partnership with Rosetta Biosciences, discovery enables simultaneous detection of multiple targets, furthering next generation of diagnostics